Selectis Health, Inc.
GBCS
$1.51
-$0.49-24.50%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -74.73% | -49.36% | -19.63% | 6.96% | 6.97% |
| Total Other Revenue | 11.91% | 8.36% | 0.09% | -4.26% | -8.82% |
| Total Revenue | 10.41% | 7.36% | -0.22% | -4.09% | -8.59% |
| Cost of Revenue | 1.88% | -3.24% | -6.40% | -4.62% | -3.31% |
| Gross Profit | 51.51% | 68.91% | 32.63% | -1.68% | -27.63% |
| SG&A Expenses | -14.95% | -18.97% | 2.13% | 15.01% | 25.93% |
| Depreciation & Amortization | -8.59% | -5.78% | -2.48% | -8.65% | -7.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.19% | -7.70% | -4.06% | -0.07% | 3.18% |
| Operating Income | 68.06% | 69.54% | 23.98% | -29.36% | -167.54% |
| Income Before Tax | 77.35% | 38.96% | -116.62% | -387.47% | -744.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 77.35% | 38.96% | -116.62% | -387.47% | -744.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.35% | 38.96% | -116.62% | -387.47% | -744.74% |
| EBIT | 68.06% | 69.54% | 23.98% | -29.36% | -167.54% |
| EBITDA | 84.34% | 84.11% | 30.29% | -48.48% | -454.21% |
| EPS Basic | 77.18% | 39.10% | -114.95% | -378.36% | -764.33% |
| Normalized Basic EPS | 56.91% | 58.74% | 17.99% | -16.53% | -94.26% |
| EPS Diluted | 76.80% | 38.55% | -115.95% | -376.85% | -770.87% |
| Normalized Diluted EPS | 56.91% | 58.74% | 17.99% | -16.53% | -94.26% |
| Average Basic Shares Outstanding | 0.31% | 0.41% | 0.31% | 0.20% | 0.10% |
| Average Diluted Shares Outstanding | 0.31% | 0.41% | 0.31% | 0.20% | 0.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 1.00% | 1.00% | -1.00% |